<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PVS</journal-id>
<journal-id journal-id-type="hwp">sppvs</journal-id>
<journal-id journal-id-type="nlm-ta">Perspect Vasc Surg Endovasc Ther</journal-id>
<journal-title>Perspectives in Vascular Surgery and Endovascular Therapy</journal-title>
<issn pub-type="ppub">1531-0035</issn>
<issn pub-type="epub">1521-5768</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1531003512454581</article-id>
<article-id pub-id-type="publisher-id">10.1177_1531003512454581</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Focus on Varicose Veins</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Thromboprophylaxis Practices Following Varicose Veins Surgery</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Nikolopoulos</surname><given-names>Evagelos S.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512454581">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Charalampidis</surname><given-names>Dimitrios G.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512454581">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Georgakarakos</surname><given-names>Efstratios I.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512454581">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Georgiadis</surname><given-names>George S.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512454581">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lazarides</surname><given-names>Miltos K.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1531003512454581">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1531003512454581"><label>1</label>“Demokritus” University of Thrace, University General Hospital of Alexandroupolis, Alexandroupolis, Greece</aff>
<author-notes>
<corresp id="corresp1-1531003512454581">George S. Georgiadis, MD, Alexandrou Papanastasiou 7 Str, Alexandroupolis, Greece, 68100 Email: <email>ggeorgia@med.duth.gr</email>; <email>docvasc@otenet.gr</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2012</year>
</pub-date>
<volume>24</volume>
<issue>2</issue>
<fpage>80</fpage>
<lpage>86</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p><italic>Objective</italic>. It is not clear whether patients undergoing varicose veins operations should receive thromboprophylaxis. A nationwide survey was conducted to assess thromboprophylaxis practice patterns in patients undergoing conventional vein surgery or endovenous procedures. <italic>Methods</italic>. A questionnaire was e-mailed to all members of the Greek Society of Vascular and Endovascular Surgery (n = 163). <italic>Results</italic>. In all, 68 members (42%) returned the survey, and 53% reported that they were not performing endovenous procedures. Thromboprophylaxis was used routinely by 52% after conventional surgery and 58% after endovenous procedures. Low-molecular-weight heparin was the preferred type of prophylaxis. Risk factors justifying thromboprophylaxis varied considerably among respondents. Postoperative duplex was performed routinely by 48% following stripping and by 76% following endovascular procedures. <italic>Conclusion</italic>. Thromboprophylaxis practices following varicose veins procedures vary among vascular surgeons in Greece. This reflects the uncertainty regarding the exact incidence of thromboembolic events in the existing literature as well as the absence of specific guidelines.</p>
</abstract>
<kwd-group>
<kwd>varicose veins</kwd>
<kwd>stripping</kwd>
<kwd>thermal ablation</kwd>
<kwd>thromboprophylaxis</kwd>
<kwd>postoperative DVT</kwd>
<kwd>survey</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1531003512454581" sec-type="intro">
<title>Introduction</title>
<p>The most serious complication after varicose vein surgery is a thromboembolic event—either deep vein thrombosis (DVT) or pulmonary embolism; interestingly, their exact incidence, although rare, is not well known. Despite the existence of detailed guidelines regarding thromboembolic event prevention, there are sparse reports regarding thromboprophylaxis following varicose veins surgery. Moreover, the impact of the existing guidelines on surgeon attitudes and practices is unclear, especially because these are not detailed regarding varicose veins surgery when additional risk factors are present.<sup><xref ref-type="bibr" rid="bibr1-1531003512454581">1</xref><xref ref-type="bibr" rid="bibr2-1531003512454581"/>-<xref ref-type="bibr" rid="bibr3-1531003512454581">3</xref></sup>
</p>
<p>The aim of this study was to assess current trends in opinions and practice patterns regarding prophylaxis after varicose veins surgery among vascular surgeons, members of the Greek Society of Vascular and Endovascular Surgery.</p>
</sec>
<sec id="section2-1531003512454581" sec-type="methods">
<title>Methods</title>
<p>To study the practice of thromboprophylaxis in Greece after varicose veins surgery, a semiclosed questionnaire was developed, consisting of 10 different questions (<xref ref-type="app" rid="app1-1531003512454581">appendix</xref>). The first question dealt with the degree of incorporation of the new endovenous procedures into everyday practice. Questions 2 to 8 assessed the main aspects of thromboprophylaxis use as well as the postoperative Duplex follow-up and patient information on possible DVT symptoms. Finally, the last 2 questions concern postinterventional mobilization and elastic stocking use. Each question was further divided into 2 parts, with 1 part assessing current prophylaxis practice in conventional surgical repair and a second identical part assessing endovenous techniques. The response frames in questions 2, 7, and 8 used a Likert scale. The target group for the questionnaire was vascular surgeons considered more skilled in varicose veins surgery. After obtaining permission from the Greek Society of Vascular and Endovascular Surgery, an e-mail outlining the aims of the study, with the questionnaire attached, was sent to all vascular surgeons who were members of the society (n = 163); nonvascular surgeons members and trainees were excluded. Then 10 days later, a single reminder e-mail was sent only to nonrespondents. A minority of the participants was contacted by phone, but only to retrieve their e-mail address.</p>
<p>Statistical analysis was performed using Statistica version 7 (StatSoft, Tulsa, OK). Data were expressed as means ± standard deviation (SD) when normally distributed or else medians ± interquartile range. Spearman rank-order correlation was used to compare practices between conventional and endovenous repairs, and the <italic>t</italic> test was used for comparison of quantitative variables; <italic>P</italic> &lt;·05 was considered significant.</p>
</sec>
<sec id="section3-1531003512454581" sec-type="results">
<title>Results</title>
<p>Of the 163 vascular surgeons contacted, 68 (42%) returned the survey. Approximately one half of the respondents (53%; 36/68) reported that they were not performing any endovenous procedures but only conventional surgery. Those using endovenous procedures reported using these with a median rate of 30% (interquartile range 20%-70%) among their cases, consisting of a median rate of 15% using endovenous laser ablation, 17% using radiofrequency ablation, and 10% using foam sclerotherapy.</p>
<p>We found that 52% of the vascular surgeons were using thromboprophylaxis routinely when performing conventional varicose veins surgery and 58% when using endovenous procedures (<xref ref-type="table" rid="table1-1531003512454581">Table 1</xref>). There was a close correlation between thromboprophylaxis practice in conventional surgery and endovenous procedures (Spearman’s ρ = 0.74)</p>
<table-wrap id="table1-1531003512454581" position="float">
<label>Table 1.</label>
<caption>
<p>Frequency of Thromboprophylaxis Use in Varicose Veins Surgery Based on the Answers of 68 Vascular Surgeons</p>
</caption>
<graphic alternate-form-of="table1-1531003512454581" xlink:href="10.1177_1531003512454581-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Traditional Varicose Veins Surgery</th>
<th align="center">Endovenous Procedures</th>
</tr>
</thead>
<tbody>
<tr>
<td>Always</td>
<td>52% (35/67)</td>
<td>58% (18/31)</td>
</tr>
<tr>
<td>Frequently</td>
<td>10% (7/67)</td>
<td>6% (2/31)</td>
</tr>
<tr>
<td>Rarely</td>
<td>36% (24/67)</td>
<td>29% (9/31)</td>
</tr>
<tr>
<td>Never</td>
<td>2% (1/67)</td>
<td>6% (2/31)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Low-molecular-weight heparin (LMWH) was used almost unanimously as the preferred type of thromboprophylaxis—by 95% (60/63) of the vascular surgeons in conventional surgery (3 surgeons reported the use of mechanical methods only, and 3 specified antithrombotic stockings) and 100% of surgeons in endovenous procedures. It was interesting to note that there was no report of use of other types of heparin or fondaparinux.</p>
<p>LMWH thromboprophylaxis was initiated postoperatively by most vascular surgeons (57%), and the selected duration by the majority of them (66%) was 1 or 2 doses in traditional stripping. In contrast, in endovenous procedures, LMWH thromboprophylaxis was initiated by 67% postprocedurally, and the majority (52%) reported continuation of prophylaxis beyond the first 2 doses.</p>
<p>Only 5 risk factors were considered as justifying thromboprophylaxis by more than 50% of those vascular surgeons using prophylaxis selectively in conventional surgery. These risk factors were known thrombophilia, history of DVT, obesity, history of malignancy, and oral contraceptive use or hormone replacement therapy (<xref ref-type="table" rid="table2-1531003512454581">Table 2</xref>). Thromboprophylaxis was applied in endovenous procedures by 64% of those using prophylaxis selectively when known thrombophilia was present and by 55% when obesity or history of DVT was present. The reasons given for not using thromboprophylaxis among those never using prophylaxis or using it selectively are depicted in <xref ref-type="table" rid="table3-1531003512454581">Table 3</xref>.</p>
<table-wrap id="table2-1531003512454581" position="float">
<label>Table 2.</label>
<caption>
<p>Risk Factors Reported as Justifying Thromboprophylaxis in Conventional Varicose Veins Surgery by Vascular Surgeons Using Prophylaxis Selectively</p>
</caption>
<graphic alternate-form-of="table2-1531003512454581" xlink:href="10.1177_1531003512454581-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Number of Surgeons Considering Thromboprophylaxis</th>
</tr>
</thead>
<tbody>
<tr>
<td>Known thrombophilia</td>
<td>94% (29/31)</td>
</tr>
<tr>
<td>History of DVT</td>
<td>87% (27/31)</td>
</tr>
<tr>
<td>Obesity</td>
<td>81% (25/31)</td>
</tr>
<tr>
<td>History of malignancy</td>
<td>65% (20/31)</td>
</tr>
<tr>
<td>Oral contraceptives/Hormone replacement therapy</td>
<td>55% (17/31)</td>
</tr>
<tr>
<td>Family history of DVT</td>
<td>45% (14/31)</td>
</tr>
<tr>
<td>Bilateral surgery</td>
<td>32% (10/31)</td>
</tr>
<tr>
<td>Age more than a certain level</td>
<td>26% (8/31)</td>
</tr>
<tr>
<td>Bilateral varicose veins, surgery on 1 leg</td>
<td>19% (6/31)</td>
</tr>
<tr>
<td>Duration of surgery</td>
<td>19% (6/31)</td>
</tr>
<tr>
<td>Recurrent varicose veins</td>
<td>10% (3/31)</td>
</tr>
<tr>
<td>Type of anesthesia</td>
<td>10% (3/31)</td>
</tr>
<tr>
<td>Smoking</td>
<td>6% (2/31)</td>
</tr>
<tr>
<td>CEAP classification</td>
<td>6% (2/31)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1531003512454581">
<p>Abbreviations: CEAP, a comprehensive classification system of chronic venous disorders including a description of the clinical class (C) based upon objective signs; the etiology (E); the anatomical (A) distribution of reflux and obstruction in the superficial, deep, and perforating veins; and the underlying pathophysiology (P), whether due to reflux or obstruction; DVT, deep vein thrombosis.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-1531003512454581" position="float">
<label>Table 3.</label>
<caption>
<p>Rationale of Not Using Thromboprophylaxis Among Those Vascular Surgeons Using It Selectively or Never</p>
</caption>
<graphic alternate-form-of="table3-1531003512454581" xlink:href="10.1177_1531003512454581-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Traditional Surgery</th>
<th align="center">Endovenous Procedures</th>
</tr>
</thead>
<tbody>
<tr>
<td>Concern for hematoma</td>
<td>21% (6/28)</td>
<td>33% (3/9)</td>
</tr>
<tr>
<td>No evidence-based practice</td>
<td>54% (15/28)</td>
<td>44% (4/9)</td>
</tr>
<tr>
<td>No need because of early mobilization</td>
<td>79% (22/28)</td>
<td>80% (8/10)</td>
</tr>
<tr>
<td>No need due to use of stockings</td>
<td>68% (19/28)</td>
<td>70% (7/10)</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Postoperative duplex monitoring was performed routinely by 48% and selectively by 23% of the vascular surgeons following conventional surgery and by 76% and 18%, respectively, following endovascular procedures. There was loose correlation regarding postoperative duplex monitoring strategy between conventional surgery and endovenous procedures (Spearman’s ρ = 0.6).</p>
<p>The majority of the vascular surgeons who participated informed the patients preoperatively routinely (72%) or selectively (23%) of the possibility and clinical picture of DVT following traditional surgery. The corresponding figures following endovascular procedures were 76% and 18% (Spearman’s ρ = 0.82).</p>
<p>Patients were mobilized 5.4 ± 4.3 hours postoperatively (mean ± 1 SD) following traditional surgery and 2.6 ± 4.1 hours (mean ± 1 SD) following endovenous procedures (<italic>t</italic> test, <italic>P</italic> = .002). They were instructed to wear stockings for 90 ± 177 days (mean ± 1 SD) following traditional surgery and for 45.3 ± 67 (mean ± 1 SD) days postdischarge following endovenous procedures (<italic>t</italic> test, <italic>P</italic> = .17).</p>
</sec>
<sec id="section4-1531003512454581" sec-type="discussion">
<title>Discussion</title>
<p>There is no consensus as to whether patients undergoing varicose vein surgery should receive thromboprophylaxis routinely. The recently published Society for Vascular Surgery and American Venous Forum guidelines similarly to the NICE (National Institute for Health and Clinical Excellence) and ACCP (American College of Chest Physicians) guidelines recommend that patients undergoing minor or short-duration (&lt;60 minutes) surgery without any additional thromboembolic risk factors should not receive specific prophylaxis routinely other than early and frequent ambulation.<sup><xref ref-type="bibr" rid="bibr1-1531003512454581">1</xref><xref ref-type="bibr" rid="bibr2-1531003512454581"/>-<xref ref-type="bibr" rid="bibr3-1531003512454581">3</xref></sup> For those with additional risk factors, such as varicose veins, they recommend prophylaxis with LMWH, unfractionated heparin, or fondaparinux.<sup><xref ref-type="bibr" rid="bibr1-1531003512454581">1</xref>,<xref ref-type="bibr" rid="bibr3-1531003512454581">3</xref></sup> In the revised last version of the ACCP guidelines for the prevention of venous thromboembolism (VTE) in nonorthopedic surgical patients, varicose veins are considered to be a risk factor as a parameter of the Caprini risk assessment model.<sup><xref ref-type="bibr" rid="bibr3-1531003512454581">3</xref></sup> However, there is no specific recommendation for thromboprophylaxis in varicose veins surgery. Thus, the following question arises: Do the varicose veins remain a risk factor after saphenectomy, given that they have already been removed during the operation? This is an issue that should be clarified. Data to support routine administration of thromboprophylaxis with heparin following endovenous procedures are also not available. For high-risk patients, several interventionists use a single, preventive dose of LMWH before or at the beginning of the procedure, although data on the effectiveness of such prophylaxis are not available.<sup><xref ref-type="bibr" rid="bibr1-1531003512454581">1</xref></sup>
</p>
<p>The incidence of thromboembolic events after vein stripping is not well known. Historically, Lofgren et al<sup><xref ref-type="bibr" rid="bibr4-1531003512454581">4</xref></sup> reported a pulmonary embolism incidence of 0.39% among 4080 operations for varicose veins at the Mayo Clinic and concluded that prophylactic postoperative anticoagulant treatment in those with a thrombotic background appears to be justified. Several retrospective series, mostly during the 1990s, reported a very low incidence of thromboembolic complications following conventional surgery, ranging from 0.1% to 0.7% (<xref ref-type="table" rid="table4-1531003512454581">Table 4</xref>).<sup><xref ref-type="bibr" rid="bibr5-1531003512454581">5</xref><xref ref-type="bibr" rid="bibr6-1531003512454581"/><xref ref-type="bibr" rid="bibr7-1531003512454581"/><xref ref-type="bibr" rid="bibr8-1531003512454581"/><xref ref-type="bibr" rid="bibr9-1531003512454581"/>-<xref ref-type="bibr" rid="bibr10-1531003512454581">10</xref></sup> However, in a recent prospective study where all patients underwent follow-up duplex scanning 2 to 4 weeks after surgery, an incidence of 5.3% was reported.<sup><xref ref-type="bibr" rid="bibr11-1531003512454581">11</xref></sup> Similarly, following endovenous procedures, the incidence of thromboembolic complications was low, at &lt;1%, in several retrospective series,<sup><xref ref-type="bibr" rid="bibr12-1531003512454581">12</xref>,<xref ref-type="bibr" rid="bibr13-1531003512454581">13</xref></sup> whereas in other series, including a prospective one, that incidence was found to be increased, at 6.8% to 16%.<sup><xref ref-type="bibr" rid="bibr14-1531003512454581">14</xref><xref ref-type="bibr" rid="bibr15-1531003512454581"/>-<xref ref-type="bibr" rid="bibr16-1531003512454581">16</xref></sup> It seems that calf vein thrombosis following conventional surgery is sometimes undetected and therefore underreported, whereas proximal thrombosis at the popliteal level or higher is rare. The latter was confirmed in a prospective study of 2805 patients assessed with duplex before discharge, where the incidence of proximal thrombosis, because calf veins were not assessed, was only 0.03%; interestingly, all received LMWH prophylaxis.<sup><xref ref-type="bibr" rid="bibr17-1531003512454581">17</xref></sup> Regarding endovenous procedures, there is also some concern about the exact incidence of thromboembolic complications.<sup><xref ref-type="bibr" rid="bibr18-1531003512454581">18</xref></sup>
</p>
<table-wrap id="table4-1531003512454581" position="float">
<label>Table 4.</label>
<caption>
<p>Incidence of Thromboembolic Complications Following Conventional or Endovenous Varicose Veins Repair</p>
</caption>
<graphic alternate-form-of="table4-1531003512454581" xlink:href="10.1177_1531003512454581-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Author/Year</th>
<th align="center">No. of Patients</th>
<th align="center">Incidence of TEE (%)</th>
<th align="center">Study Type</th>
<th align="center">Treatment Type</th>
<th align="center">Heparin Prophylaxis</th>
</tr>
</thead>
<tbody>
<tr>
<td>Marsh et al<sup><xref ref-type="bibr" rid="bibr12-1531003512454581">12</xref></sup>/2010</td>
<td>2820</td>
<td>0.7</td>
<td>Retrospective</td>
<td>EVLA*RFA</td>
<td>Routinely</td>
</tr>
<tr>
<td>Frings et al<sup><xref ref-type="bibr" rid="bibr17-1531003512454581">17</xref></sup>/2006</td>
<td>2805</td>
<td>0.03</td>
<td>Prospective<sup><xref ref-type="table-fn" rid="table-fn3-1531003512454581">a</xref></sup></td>
<td>Stripping</td>
<td>Routinely</td>
</tr>
<tr>
<td>Mozes et al<sup><xref ref-type="bibr" rid="bibr16-1531003512454581">16</xref></sup>/2005</td>
<td>41</td>
<td>7.7</td>
<td>Not reported</td>
<td>EVLA</td>
<td>NR</td>
</tr>
<tr>
<td>van Rij et al<sup><xref ref-type="bibr" rid="bibr11-1531003512454581">11</xref></sup>/2004</td>
<td>377</td>
<td>5.3</td>
<td>Prospective<sup><xref ref-type="table-fn" rid="table-fn3-1531003512454581">a</xref></sup></td>
<td>Stripping</td>
<td>Selectively</td>
</tr>
<tr>
<td>Hingorani et al<sup><xref ref-type="bibr" rid="bibr14-1531003512454581">14</xref></sup>/2004</td>
<td>66</td>
<td>16</td>
<td>Prospective<sup><xref ref-type="table-fn" rid="table-fn3-1531003512454581">a</xref></sup></td>
<td>RFA</td>
<td>NR</td>
</tr>
<tr>
<td>Merchant et al<sup><xref ref-type="bibr" rid="bibr13-1531003512454581">13</xref></sup>/2003</td>
<td>1150</td>
<td>0.4</td>
<td>Prospective</td>
<td>RFA</td>
<td>NR</td>
</tr>
<tr>
<td>Enoch et al<sup><xref ref-type="bibr" rid="bibr5-1531003512454581">5</xref></sup>/2003</td>
<td>2186</td>
<td>0.1</td>
<td>Retrospective</td>
<td>Stripping</td>
<td>Selectively</td>
</tr>
<tr>
<td>Komenaka and Nguyen<sup><xref ref-type="bibr" rid="bibr15-1531003512454581">15</xref></sup>/2002</td>
<td>29</td>
<td>6.8</td>
<td>Not reported</td>
<td>RFA</td>
<td>NR</td>
</tr>
<tr>
<td>Critchley et al<sup><xref ref-type="bibr" rid="bibr7-1531003512454581">7</xref></sup>/1997</td>
<td>599</td>
<td>0.5</td>
<td>Retrospective</td>
<td>Stripping or HSL*Av</td>
<td>Selectively</td>
</tr>
<tr>
<td>Miller et al<sup><xref ref-type="bibr" rid="bibr6-1531003512454581">6</xref></sup>/1996</td>
<td>997</td>
<td>0.5</td>
<td>Retrospective</td>
<td>Stripping or HSL*Av</td>
<td>NR</td>
</tr>
<tr>
<td>Bounameaux and Huber<sup><xref ref-type="bibr" rid="bibr8-1531003512454581">8</xref></sup>/1996</td>
<td>1063</td>
<td>0.5</td>
<td>Retrospective</td>
<td>Stripping</td>
<td>NR</td>
</tr>
<tr>
<td>Hagmuller<sup><xref ref-type="bibr" rid="bibr9-1531003512454581">9</xref></sup>/1992</td>
<td>3300</td>
<td>0.2</td>
<td>Retrospective</td>
<td>Stripping or HSL*Av</td>
<td>NR</td>
</tr>
<tr>
<td>Keith and Smead<sup><xref ref-type="bibr" rid="bibr10-1531003512454581">10</xref></sup>/1983</td>
<td>544</td>
<td>0.7</td>
<td>Retrospective</td>
<td>Stripping</td>
<td>NR</td>
</tr>
<tr>
<td>Lofgren et al<sup><xref ref-type="bibr" rid="bibr4-1531003512454581">4</xref></sup>/1976</td>
<td>4080</td>
<td>0.39</td>
<td>Retrospective</td>
<td>Stripping</td>
<td>NR</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1531003512454581">
<p>Abbreviations: TEE, thromboembolic event; HSL*Av, high saphenous ligation and avulsions; EVLA, endovenous laser ablation; RFA, radiofrequency ablation; NR, not reported.</p></fn>
<fn id="table-fn3-1531003512454581">
<label>a</label>
<p>All patients underwent follow-up venous duplex scanning.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>In this survey, Greek vascular surgeons were found to use prophylaxis routinely with LMWH at rates of 52% and 58%, respectively, when varicose veins surgery or thermal ablation was performed. This is a much higher percentage of LMWH use than has been seen in 1 previous similar survey among members of the UK Society of Vascular Surgery, where only 12% were using such prophylaxis routinely for varicose veins surgery.<sup><xref ref-type="bibr" rid="bibr19-1531003512454581">19</xref></sup> Regarding risk factors reported as justifying thromboprophylaxis, there was considerable variation among respondents because the literature does not provide undisputable data on the risk of DVT after varicose veins surgery. Among the reasons reported for not using prophylaxis, 50% of the respondents stated that LMWH use is not evidence based, whereas 80% believe that there is no need for thromboprophylaxis because of the early mobilization and use of stockings, the latter considered to be a mechanical thromboprophylaxis precaution.</p>
<p>It was surprising that the majority of the responding surgeons did not consider bilateral procedures, older age, or duration of surgery as risk factors in their selective use of LMWH, whereas they used prophylaxis in those with known thrombophilia and history of DVT or malignancy, in obese individuals, and in those on contraceptives. It should be underlined that both age and duration of surgery are considered to be additional risk factors that affect VTE incidence in surgical patients according to both NICE and ACCP guidelines.<sup><xref ref-type="bibr" rid="bibr2-1531003512454581">2</xref>,<xref ref-type="bibr" rid="bibr3-1531003512454581">3</xref></sup>
</p>
<p>Significantly different practices were noticed between conventional surgery and endovenous procedures. Postope rative use of Duplex was not a routine for most surgeons following conventional surgery, whereas 76% were using it following endovenous procedures. It is noteworthy that not all surgeons were using postprocedural Duplex scanning following endovenous ablation within 24 to 72 hours to exclude heat-induced thrombus extension as recommended by the Society for Vascular Surgery and the American Venous Forum guidelines.<sup><xref ref-type="bibr" rid="bibr1-1531003512454581">1</xref></sup> Similarly, patients were mobilized earlier after endovenous procedures than following conventional surgery and were instructed to wear stockings for a shorter period in accordance with the view that the additional use of compression stockings made no difference to the outcome following obliteration of veins.<sup><xref ref-type="bibr" rid="bibr20-1531003512454581">20</xref></sup>
</p>
<p>Unfortunately, such studies usually face some limitations. In this study, the restricted number of responses, 68 of 123 (42%), cannot be overlooked. On the other hand, although less than half of the vascular surgeon members of the Greek Society of Vascular and Endovascular Surgery responded in the survey, a participation percentage of 42% is thought to be a reliable statistical sample. Moreover, LMWH administration protocols and exact surgical practices, such as duration of the procedure and type of anesthesia, are not described in full detail in the present questionnaire. Additionally, experience and surgery results of individual surgeons may vary widely, affecting the results of this survey. If we add to this the fact that such studies are often subject to significant bias being directed toward overreporting of interventions, it is likely that the real rate of thromboprophylaxis is lower than reported.</p>
<p>However, this study is a survey, and it just depicts the current trends in thromboprophylaxis practices after varicose veins surgery. One may clearly conclude that such practices vary among vascular surgeons in Greece. This is not a finding unique to Greece; great variation in the use of various types of thromboprophylaxis recommended by the ACCP in patients at risk of VTE was recorded worldwide in the ENDORSE study.<sup><xref ref-type="bibr" rid="bibr21-1531003512454581">21</xref></sup>
</p>
<p>Even though varicose veins surgery is a routine for almost every vascular surgeon, a low but appreciable risk of severe adverse events, such as DVT and pulmonary embolism, still exists. Although prevention is thought to be the best strategy, specific data are confusing in the current literature. This study outlines the lack of a consensus in thromboprophylaxis practices during everyday varicose veins surgery and underlines the need for evidence-based guidelines because medicolegal complications may occur, considering the variability in everyday practice.</p>
</sec>
</body>
<back>
<app-group>
<app id="app1-1531003512454581">
<title>Appendix</title>
<sec id="section5-1531003512454581">
<title>Thromboprophylaxis in Varicose Veins (Vv) Treatment: Questionnaire (Translated From Greek)</title>
<list id="list1-1531003512454581" list-type="order">
<list-item><p>1) Do you use endovenous procedures and in what percentage and type?</p></list-item>
</list>
<p>Yes: ………</p>
<p>No: ……….</p>
<p>Percentage of the total: ……….</p>
<p> Laser:……… RF:……… Foam:………</p>
<list id="list2-1531003512454581" list-type="simple">
<list-item><p>2) Do you use some kind of thromboprophylaxis after VV surgery?</p></list-item>
</list>
<table-wrap id="table5-1531003512454581" position="float">
<graphic alternate-form-of="table5-1531003512454581" xlink:href="10.1177_1531003512454581-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Surgical repair</th>
<th align="center">Endovenous repair</th>
</tr>
</thead>
<tbody>
<tr>
<td>Always</td>
<td/>
<td/>
</tr>
<tr>
<td>Frequently</td>
<td/>
<td/>
</tr>
<tr>
<td>Rarely</td>
<td/>
<td/>
</tr>
<tr>
<td>Never</td>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<list id="list3-1531003512454581" list-type="simple">
<list-item><p>3) Which thromboprophylaxis method do you prefer?</p></list-item>
</list>
<table-wrap id="table6-1531003512454581" position="float">
<graphic alternate-form-of="table6-1531003512454581" xlink:href="10.1177_1531003512454581-table6.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Surgical repair</th>
<th align="center">Endovenous repair</th>
</tr>
</thead>
<tbody>
<tr>
<td>LMWH</td>
<td/>
<td/>
</tr>
<tr>
<td>Classic Heparin</td>
<td/>
<td/>
</tr>
<tr>
<td>Other medication (describe)</td>
<td/>
<td/>
</tr>
<tr>
<td>Mechanical measures only (describe)</td>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<list id="list4-1531003512454581" list-type="simple">
<list-item><p>4) If you use thromboprophylaxis, what is your practice?</p></list-item>
</list>
<table-wrap id="table7-1531003512454581" position="float">
<graphic alternate-form-of="table7-1531003512454581" xlink:href="10.1177_1531003512454581-table7.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="2">Surgical repair</th>
<th align="center" colspan="2">Endovenous repair</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="4">Start of prophylaxis</td>
</tr>
<tr>
<td>Preoperatively:</td>
<td>Postoperatively:</td>
<td>Preoperatively:</td>
<td>Postoperatively:</td>
</tr>
<tr>
<td colspan="4">Doses</td>
</tr>
<tr>
<td>1-2:</td>
<td>More than 2:</td>
<td>1-2:</td>
<td>More than 2:</td>
</tr>
</tbody>
</table>
</table-wrap>
<list id="list5-1531003512454581" list-type="simple">
<list-item><p>5) If you use prophylaxis selectively which of the following risk factors justifies thromboprofylaxis?</p></list-item>
</list>
<table-wrap id="table8-1531003512454581" position="float">
<graphic alternate-form-of="table8-1531003512454581" xlink:href="10.1177_1531003512454581-table8.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Surgical repair</th>
<th align="center">Endovenous repair</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age above a certain level (describe)</td>
<td/>
<td/>
</tr>
<tr>
<td>Obesity</td>
<td/>
<td/>
</tr>
<tr>
<td>VV recurrence</td>
<td/>
<td/>
</tr>
<tr>
<td>Bilateral VV surgery</td>
<td/>
<td/>
</tr>
<tr>
<td>Bilateral VV, surgery on one leg</td>
<td/>
<td/>
</tr>
<tr>
<td>Duration of surgery (describe)</td>
<td/>
<td/>
</tr>
<tr>
<td>History of DVT</td>
<td/>
<td/>
</tr>
<tr>
<td>Family history of DVT</td>
<td/>
<td/>
</tr>
<tr>
<td>Oral contraceptives/hormone replacement therapy</td>
<td/>
<td/>
</tr>
<tr>
<td>Smoking</td>
<td/>
<td/>
</tr>
<tr>
<td>Known thrombophilia</td>
<td/>
<td/>
</tr>
<tr>
<td>History of malignancy</td>
<td/>
<td/>
</tr>
<tr>
<td>Type of anesthesia (describe)</td>
<td/>
<td/>
</tr>
<tr>
<td>CEAP class (describe)</td>
<td/>
<td/>
</tr>
<tr>
<td>Other (describe)</td>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<list id="list6-1531003512454581" list-type="simple">
<list-item><p>6) What is the main reason for not using thromboprophylaxis?</p></list-item>
</list>
<table-wrap id="table9-1531003512454581" position="float">
<graphic alternate-form-of="table9-1531003512454581" xlink:href="10.1177_1531003512454581-table9.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Surgical repair</th>
<th align="center">Endovenous repair</th>
</tr>
</thead>
<tbody>
<tr>
<td>Concern for hematoma</td>
<td/>
<td/>
</tr>
<tr>
<td>No evidence based practice</td>
<td/>
<td/>
</tr>
<tr>
<td>No need due to early mobilization</td>
<td/>
<td/>
</tr>
<tr>
<td>No need due to use of stockings</td>
<td/>
<td/>
</tr>
<tr>
<td>Other</td>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<list id="list7-1531003512454581" list-type="simple">
<list-item><p>7) Do you perform postoperative assessment with Duplex?</p></list-item>
</list>
<table-wrap id="table10-1531003512454581" position="float">
<graphic alternate-form-of="table10-1531003512454581" xlink:href="10.1177_1531003512454581-table10.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Surgical repair</th>
<th align="center">Endovenous repair</th>
</tr>
</thead>
<tbody>
<tr>
<td>Yes, always</td>
<td/>
<td/>
</tr>
<tr>
<td>Yes, selectively</td>
<td/>
<td/>
</tr>
<tr>
<td>No</td>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<list id="list8-1531003512454581" list-type="simple">
<list-item><p>8) Do you inform patients for possible DVT symptoms?</p></list-item>
</list>
<table-wrap id="table11-1531003512454581" position="float">
<graphic alternate-form-of="table11-1531003512454581" xlink:href="10.1177_1531003512454581-table11.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Surgical repair</th>
<th align="center">Endovenous repair</th>
</tr>
</thead>
<tbody>
<tr>
<td>Yes, always</td>
<td/>
<td/>
</tr>
<tr>
<td>Yes, selectively</td>
<td/>
<td/>
</tr>
<tr>
<td>No</td>
<td/>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<list id="list9-1531003512454581" list-type="simple">
<list-item><p>9) When do you mobilize your patients postoperatively?</p></list-item>
</list>
<p>After surgery: …………………………………………</p>
<p>After Endovenous ablation: …………………………</p>
<list id="list10-1531003512454581" list-type="simple">
<list-item><p>10) For how long do you recommend the postoperative use of stockings?</p></list-item>
</list>
<p>After surgery:…………………………………………</p>
<p>After Endovenous ablation: ………………………….</p>
</sec>
</app>
</app-group>
<ack><p>We thank the members of the Greek Society of Vascular and Endovascular Surgery who completed and returned this survey. We also thank the board of the Society for providing us with the membership list.</p></ack>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1531003512454581">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gloviczki</surname><given-names>P</given-names></name>
<name><surname>Comerota</surname><given-names>AJ</given-names></name>
<name><surname>Dalsing</surname><given-names>MC</given-names></name><etal/>
</person-group>. <article-title>The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum</article-title>. <source>J Vasc Surg</source>. <year>2011</year>;<volume>53</volume>:<fpage>2S</fpage>-<lpage>48S</lpage>.</citation>
</ref>
<ref id="bibr2-1531003512454581">
<label>2.</label>
<citation citation-type="web">
<collab>National Institute for Health and Clinical Excellence</collab>. <source>Reducing the Risk of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Patients Admitted To Hospital</source>. <publisher-loc>London, UK</publisher-loc>: <publisher-name>National Institute for Health and Clinical Excellence</publisher-name>; <year>2010</year>. <ext-link ext-link-type="uri" xlink:href="http://guidance.nice.org.uk/CG92">http://guidance.nice.org.uk/CG92</ext-link>. <access-date>Accessed July 2, 2012</access-date>.</citation>
</ref>
<ref id="bibr3-1531003512454581">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gould</surname><given-names>MK</given-names></name>
<name><surname>Garcia</surname><given-names>DA</given-names></name>
<name><surname>Wren</surname><given-names>SM</given-names></name><etal/>
</person-group>. <article-title>Prevention of VTE in non-orthopaedic surgical patients: antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians, Evidence-Based Clinical Practice Guidelines (9th edition)</article-title>. <source>Chest</source>. <year>2012</year>;<volume>141</volume>:<fpage>e227S</fpage>-<lpage>e277S</lpage>.</citation>
</ref>
<ref id="bibr4-1531003512454581">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lofgren</surname><given-names>EP</given-names></name>
<name><surname>Coates</surname><given-names>HL</given-names></name>
<name><surname>O’Brien</surname><given-names>PC</given-names></name>
</person-group>. <article-title>Clinically suspect pulmonary embolism after vein stripping</article-title>. <source>Mayo Clin Proc</source>. <year>1976</year>;<volume>51</volume>:<fpage>77</fpage>-<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr5-1531003512454581">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Enoch</surname><given-names>S</given-names></name>
<name><surname>Woon</surname><given-names>E</given-names></name>
<name><surname>Blair</surname><given-names>SD</given-names></name>
</person-group>. <article-title>Thromboprophylaxis can be omitted in selected patients undergoing varicose vein surgery and hernia repair</article-title>. <source>Br J Surg</source>. <year>2003</year>;<volume>90</volume>: <fpage>818</fpage>-<lpage>820</lpage>.</citation>
</ref>
<ref id="bibr6-1531003512454581">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miller</surname><given-names>GV</given-names></name>
<name><surname>Lewis</surname><given-names>WG</given-names></name>
<name><surname>Sainsbury</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Morbidity of varicose vein surgery: auditing the benefit of changing clinical practice</article-title>. <source>Ann R Coll Surg Engl</source>. <year>1996</year>;<volume>78</volume>:<fpage>345</fpage>-<lpage>349</lpage>.</citation>
</ref>
<ref id="bibr7-1531003512454581">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Critchley</surname><given-names>G</given-names></name>
<name><surname>Harvey</surname><given-names>A</given-names></name>
<name><surname>Handa</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Complications of varicose vein surgery</article-title>. <source>Ann R Coll Surg Engl</source>. <year>1997</year>;<volume>79</volume>:<fpage>105</fpage>-<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr8-1531003512454581">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bounameaux</surname><given-names>H</given-names></name>
<name><surname>Huber</surname><given-names>O</given-names></name>
</person-group>. <article-title>Postoperative deep vein thrombosis and surgery for varicose veins</article-title>. <source>BMJ</source>. <year>1996</year>;<volume>312</volume>:<year>1158</year>.</citation>
</ref>
<ref id="bibr9-1531003512454581">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hagmuller</surname><given-names>GW</given-names></name>
</person-group>. <article-title>Complications in surgery of varicose veins</article-title>. <source>Lagenbecks Arch Chir</source>. <year>1992</year>;<volume>377</volume>(<supplement>suppl</supplement>):<fpage>470</fpage>-<lpage>474</lpage>.</citation>
</ref>
<ref id="bibr10-1531003512454581">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Keith</surname><given-names>LM</given-names><suffix>Jr</suffix></name>
<name><surname>Smead</surname><given-names>WL</given-names></name>
</person-group>. <article-title>Saphenous vein stripping and its complications</article-title>. <source>Surg Clin North Am</source>. <year>1983</year>;<volume>63</volume>:<fpage>1303</fpage>-<lpage>1312</lpage>.</citation>
</ref>
<ref id="bibr11-1531003512454581">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Rij</surname><given-names>AM</given-names></name>
<name><surname>Chai</surname><given-names>J</given-names></name>
<name><surname>Hill</surname><given-names>GB</given-names></name><etal/>
</person-group>. <article-title>Incidence of deep vein thrombosis after varicose vein surgery</article-title>. <source>Br J Surg</source>. <year>2004</year>;<volume>91</volume>:<fpage>1582</fpage>-<lpage>1585</lpage>.</citation>
</ref>
<ref id="bibr12-1531003512454581">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marsh</surname><given-names>P</given-names></name>
<name><surname>Price</surname><given-names>BA</given-names></name>
<name><surname>Holdstock</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Deep vein thrombosis (DVT) after venous thermoablation techniques: rates of endovenous heat-induced thrombosis (EHIT) and classical DVT after radiofrequency and endovenous laser ablation in a single centre</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2010</year>;<volume>40</volume>:<fpage>521</fpage>-<lpage>527</lpage>.</citation>
</ref>
<ref id="bibr13-1531003512454581">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Merchant</surname><given-names>R</given-names><suffix>Jr</suffix></name>
<name><surname>Kistner</surname><given-names>RL</given-names></name>
<name><surname>Kabnick</surname><given-names>LS</given-names></name>
</person-group>. <article-title>Is there an increased risk for DVT with the VNUS closure procedure?</article-title> <source>J Vasc Surg</source>. <year>2003</year>;<volume>38</volume>:<fpage>628</fpage>.</citation>
</ref>
<ref id="bibr14-1531003512454581">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hingorani</surname><given-names>AP</given-names></name>
<name><surname>Ascher</surname><given-names>E</given-names></name>
<name><surname>Markevich</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>Deep venous thrombosis after radiofrequency ablation of greater saphenous vein: a word of caution</article-title>. <source>J Vasc Surg</source>. <year>2004</year>;<volume>40</volume>:<fpage>500</fpage>-<lpage>504</lpage>.</citation>
</ref>
<ref id="bibr15-1531003512454581">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Komenaka</surname><given-names>IK</given-names></name>
<name><surname>Nguyen</surname><given-names>ET</given-names></name>
</person-group>. <article-title>Is there an increased risk for DVT with the VNUS closure procedure?</article-title> <source>J Vasc Surg</source>. <year>2002</year>;<volume>36</volume>:<year>1311</year>.</citation>
</ref>
<ref id="bibr16-1531003512454581">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mozes</surname><given-names>G</given-names></name>
<name><surname>Kalra</surname><given-names>M</given-names></name>
<name><surname>Carmo</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Extension of saphenous thrombus into the femoral vein: a potential complication of new endovenous ablation techniques</article-title>. <source>J Vasc Surg</source>. <year>2005</year>;<volume>41</volume>:<fpage>130</fpage>-<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr17-1531003512454581">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Frings</surname><given-names>N</given-names></name>
<name><surname>Glowacki</surname><given-names>P</given-names></name>
<name><surname>Tran</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Varicose vein surgery: avoiding deep venous thrombosis</article-title>. <source>Phlebologie</source>. <year>2006</year>;<volume>35</volume>:<fpage>233</fpage>-<lpage>236</lpage>.</citation>
</ref>
<ref id="bibr18-1531003512454581">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Guptan</surname><given-names>RC</given-names></name>
</person-group>. <article-title>Regarding “Is there an increased risk for DVT with the VNUS closure procedure?</article-title> <source>J Vasc Surg</source>. <year>2003</year>;<volume>38</volume>:<year>1140</year>.</citation>
</ref>
<ref id="bibr19-1531003512454581">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>WB</given-names></name>
<name><surname>Ridler</surname><given-names>BMF</given-names></name>
</person-group>. <article-title>Varicose vein surgery and deep vein thrombosis</article-title>. <source>Br J Surg</source>. <year>1995</year>;<volume>82</volume>:<fpage>1494</fpage>-<lpage>1497</lpage>.</citation>
</ref>
<ref id="bibr20-1531003512454581">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hamel-Desnos</surname><given-names>CM</given-names></name>
<name><surname>Guias</surname><given-names>BJ</given-names></name>
<name><surname>Desnos</surname><given-names>PR</given-names></name><etal/>
</person-group>. <article-title>Foam sclerotherapy of the saphenous veins: randomised controlled trial with or without compression</article-title>. <source>Eur J Vasc Endovasc Surg</source>. <year>2010</year>;<volume>39</volume>:<fpage>500</fpage>-<lpage>507</lpage>.</citation>
</ref>
<ref id="bibr21-1531003512454581">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>AT</given-names></name>
<name><surname>Tapson</surname><given-names>VF</given-names></name>
<name><surname>Bergmann</surname><given-names>JF</given-names></name><etal/>
</person-group>. <article-title>Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study</article-title>. <source>Lancet</source>. <year>2008</year>;<volume>371</volume>:<fpage>387</fpage>-<lpage>394</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>